PS Ratio
1.49
0.000.00%
Thu, 06 Feb 2025 21:00:00 GMT
Summary
- As of February 7, 2025, RVNC price to sales ratio is 1.49, unchanged from the previous trading day.
- Over the past year, RVNC PS ratio has dropped by -0.63 (-29.72%).
- RVNC PS ratio is now -99.98% below its all-time high of 7869.94.
Performance
RVNC PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
RVNC PS Ratio Trends
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | 0.0% | 0.0% | 0.0% | +2.3% |
| 1 m1 month | +6.4% | +6.8% | +6.8% | - |
| 3 m3 months | -25.1% | -25.2% | -25.2% | +2.3% |
| 6 m6 months | +19.2% | +22.1% | +22.2% | - |
| ytdytd | +19.2% | +19.3% | +19.3% | - |
| 1 y1 year | -29.7% | -35.4% | -23.0% | +25.8% |
| 5 y5 years | -100.0% | -86.3% | -74.7% | +10000.0% |
RVNC PS Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -1.3% | 1.34 | +11.2% | |
| 3 m | 3-month | 2.31 | -35.5% | 1.23 | +21.1% |
| 6 m | 6-month | 2.74 | -45.6% | 1.23 | +21.1% |
| 1 y | 1-year | 2.85 | -47.7% | 1.03 | +44.7% |
| 3 y | 3-year | 23.26 | -93.6% | 1.03 | +44.7% |
| 5 y | 5-year | 7869.94 | -100.0% | 1.03 | +44.7% |
| alltime | all time | 7869.94 | -100.0% | 1.03 | +44.7% |
Revance Therapeutics PS Ratio History
| Date | Value |
|---|---|
| 2025 | 1.49(+19.2%) |
| 2024 | 1.25(-62.9%) |
| 2023 | 3.37(-70.9%) |
| 2022 | 11.59(-22.8%) |
| 2021 | 15.02(-88.3%) |
| 2020 | 127.93(-93.8%) |
| Date | Value |
|---|---|
| 2019 | 2058.21(+930.9%) |
| 2018 | 199.65(-96.0%) |
| 2017 | 4982.64(+152.1%) |
| 2016 | 1976.78(-38.6%) |
| 2015 | 3221.12(+206.3%) |
| 2014 | 1051.54 |
FAQ
- What is Revance Therapeutics price to sales ratio?
- What is the all time high PS ratio for Revance Therapeutics?
- What is RVNC price to sales ratio year-to-date change?
- What is Revance Therapeutics PS ratio year-on-year change?
What is Revance Therapeutics price to sales ratio?
The current PS ratio of RVNC is 1.49
What is the all time high PS ratio for Revance Therapeutics?
Revance Therapeutics all-time high price to sales ratio is 7869.94
What is RVNC price to sales ratio year-to-date change?
Revance Therapeutics price to sales ratio has changed by +0.24 (+19.20%) since the beginning of the year
What is Revance Therapeutics PS ratio year-on-year change?
Over the past year, RVNC price to sales ratio has changed by -0.63 (-29.72%)